Minnesota Stroke Association

ScheduleOnline Registration
Directions and AccommodationsContinuing Education Unit InformationCancellation Policy

Thursday Conference Schedule

8 - 9 a.m. - Registration and Exhibits Open

Exhibits are open 8 a.m. to 3 p.m.

8:45 - 9:15 a.m. - Opening Remarks

9:15 - 10:30 a.m. - Keynote Address

Clinical Trials in ICH from Hemostatic Therapy to Minimally Invasive Surgery and Iron-modulating Therapy: Lessons Learned and Future DirectionsMagdy Selim
Magdy Selim, MD, Ph.D., Professor of Neurology, Harvard Medical School; Chief, Division of Stroke and Cerebrovascular Disease, Department of Neurology, Beth Israel Deaconess Medical Center

Recent advances in our understanding of the pathophysiology of brain injury after intracerebral hemorrhage (ICH) coupled with unmet need for effective therapies to improve patients' outcomes have fueled clinical research in ICH. Several important clinical trials were recently concluded. Despite overall negative results, findings from these trials are instrumental to shape future trials and provide cautious optimism in our search for effective treatments for this devastating condition. The keynote speaker will review the pathophysiology of brain injury after ICH and potential therapeutic targets, and will review the lessons learned from recent trials and future directions with particular emphasis on hemostatic therapy, minimally invasive hematoma evacuation, and iron-modulating therapy.

Dr. Selim is Professor of Neurology at Harvard Medical School. He serves as the Chief of the Division of Stroke and Cerebrovascular Disease, the Director of the Comprehensive Stroke Center at Beth Israel Deaconess Medical Center in Boston. He is a fellow of the American Heart Association/American Stroke Association Stroke Council and the European Stroke Organization; the Chair of the American Neurological Association Cerebrovascular Disease and Interventional Neurology Special Interest Group; and the Co-Editor of the Controversies section of the STROKE journal.

Dr. Selim is known for his interest and research in intracerebral hemorrhage (ICH). He published more than 200 peer-reviewed articles, and recently led the efforts to establish the Hemorrhagic Stroke Academia industry (HEADS) roundtable; a think tank group comprised of leading researchers and physicians in the field, industry representatives, and decision-makers from regulatory agencies such as NINDS and FDA, aiming to improve ICH research and develop a roadmap to expedite the development of new therapies. He is the Principal Investigator of 2 NIH-funded, multi-center, international, clinical trials in ICH; the intracerebral hemorrhage Deferoxamine (iDEF) trial and Statin Use in Intracerebral Hemorrhage Patients (SATURN) trial.

10:30 - 11 a.m. - Break and Exhibits Open

11 a.m. - 12 p.m. - Breakout Sessions I

  1. Neuroprotection: New Era – New Perspective
    Magdy Selim, MD, Ph.D., Professor of Neurology, Harvard Medical School; Chief, Division of Stroke and Cerebrovascular Disease, Department of Neurology, Beth Israel Deaconess Medical Center
    The concept of neuroprotection is not new. Countless neuroprotective agents have been tested and failed in clinical stroke trials over the past 20 years. The concept of neuroprotection is regaining enthusiasm with increased use of mechanical reperfusion in ischemic stroke and rising interest in hemorrhagic stroke. The speaker will review potential new neuroprotective strategies and new concepts in both ischemic and hemorrhagic stroke.

  2. Now – Show Me Your Teeth! A Review and Practice of the NIH Stroke Scale
    Joan Somes, RN-BC, MSN, Ph.D., CEN, CPEN, FAEN, NRP, Critical Care Educator, Regions Hospital EMS
    The NIH Stroke Scale assessment provides information on the patient's brain function and neurological status, as well as a method of consistently recording symptoms. The more one performs the standardized assessment, the easier it becomes. This session will review the steps and then practice using videos of recorded NIH stroke scale assessments being completed.

  3. Stroke Rehabilitation at the Minneapolis VA: An Interdisciplinary Approach
    Minneapolis Veterans Administration Medical Center: Traci L. Boser, LICSW, Stroke Program Coordinator; Amanda Momin, RN, Assistant Nurse Manager, Polytrauma Rehabilitation Unit; Evan Beranek, Assistant Nurse Manager, Polytrauma Rehabilitation Unit; Julie Mehr, Occupational Therapist, Clinical Specialist in Neuro Rehabilitation; Susan Bernstein, Speech Language Pathologist, Polytrauma Rehabilitation Unit
    The Minneapolis VA has an 18-bed acute rehab unit that serves veterans who have suffered a stroke. Our stroke inpatient unit is CARF accredited and uses an interdisciplinary approach to provide rehab services. In addition to the traditional rehab model that includes physical therapy, occupational therapy and speech therapy, our team also includes vision therapy, rehab psychology, psychiatry, assistive technology and recreational therapy.

  4. New Cardiac Devices for Stroke Prevention
    Regions Hospital: Haitham M. Hussein, MD, MSc, FAHA, FAAN, Medical Director, Comprehensive Stroke Center; Johannes Brechtken, MD, Medical Director of Interventional Cardiology; Marit Thorsgard, MD, Interventional Cardiologist
    After years of debate and uncertainty, several recent trials have shown the safety and efficacy of patent foramen ovale (PFO) closure and left atrial appendage closure devices for stroke prevention. In this session, the presenters will review the history of these devices and the evolution of the evidence supporting their use. They will then share an institutional protocol developed by a team assembled from the neurology and cardiology departments.

  5. Health Rhythms: Drumming for Your Health
    Monica B. Peterson, Social Worker
    Research shows drumming benefits overall health and wellness as a means of communication and musical expression. For people who have experienced a stroke, a drum acts as an additional adaptable treatment technique for communication as well as physical exercise. Open to all; no music or drumming experience necessary.

12 - 1 p.m. - Lunch

1 - 2 p.m. - Breakout Session II

  1. Customizing Antiplatelet Therapy for Secondary Stroke Prevention
    Christopher Streib, MD, MS, Vascular Neurologist, University of Minnesota
    Customizing antiplatelet therapy based upon stroke etiology is a promising avenue for maximizing secondary stroke prevention. There is increasing evidence that patient-specific characteristics including stroke subtype and timing determine optimal antiplatelet regimen. This presentation will review the indications and evidence for choosing between dual antiplatelet therapy and antiplatelet monotherapy, as well as considerations for which antiplatelet agent and duration of treatment.

  2. Pediatric Stroke
    Alexander Drofa, MD, FRCSC, Neurovascular Medical Director, Sanford Health
    This session will heighten awareness of pediatric stroke and treatment options in our region. Presenter will also identify risk factors and etiologies for pediatric patients and discuss treatment options and recommended imaging. Case scenarios will be reviewed.

  3. Building Therapeutic Alliance: Strengthen Relationships & Improve Outcomes
    Peter Freeborn, PT, DPT, Physical Therapist, Regions Hospital
    Therapeutic Alliance (TA) is how we connect and effect positive changes. The theory is rooted in psychology. However, in recent years the model has been researched, refined and specifically applied to PT. This session provides a framework of TA, communication techniques, and examines evidence of improved outcomes with strengthened TA.

  4. Post Acute Care: Stroke Rehabilitation
    Rachael Towers, MSN, RN, CRRN, RN Program Manager, Sanford Health; Jenny Marsden, PC-C, MPT, Physician Assistant for Physical Medicine and Rehabilitation Sanford Health
    High-quality rehab will help ensure that patients with stroke reach their full recovery potential over a continuum of care. In addition, the American Heart Association and American Stroke Association recommend an inpatient rehab setting first if the patient is able to tolerate the intensity of the program. However, in order to develop predicted outcomes and establish an interdisciplinary plan of care, a comprehensive assessment of the individual is required to identify medical and rehabilitation needs. This presentation will review the admission criteria for an inpatient rehabilitation stay, the rehabilitation interdisciplinary team, as well as other levels of care and transition if stroke patients are not able to tolerate the intensity of inpatient rehabilitation.

  5. It Says Take Three Pills A Day. I Take Them All In The Morning So I Don't Forget.
    Joan Somes, RN-BC, MSN, PhD, CEN, CPEN, FAEN, NRP, Critical Care Educator, Regions Hospital EMS
    Half the country has difficulty reading and understanding instructions due to low health literacy. A stroke may cause more challenges, and if family members have low health literacy, they may not be able to help. This session will outline indications of those difficulties and actions one can take to help facilitate understanding.

2 - 2:30 p.m. - Break and Exhibits Open

2:30 - 3:30 p.m. - Breakout Session II

  1. Thrombolysis Beyond Conventional Time Windows
    Christopher Streib, MD, MS, Vascular Neurologist, University of Minnesota
    Treatment with Alteplase beyond 4.5 hours from the last known time was shown to be beneficial in two recent randomized controlled trials using advanced neuroimaging. This session will provide an overview of these trials including the underlying principles of qualifying neuroimaging and overall risk-benefit.

  2. Stroke and Other Anomalies
    Alexander Drofa, MD, FRCSC, Neurovascular Medical Director, Sanford Health
    This talk will discuss various stroke anomalies, methods for achieving a diagnosis, and treatment options. It will identify what ECIC is and when it is used. There will be a discussion on endovascular treatment options for Venous Sinus Thrombosis, and it will review how to identify various stroke anomalies.

  3. Addressing Professional Burnout/Compassion Fatigue While Working With Persons Following Stroke
    Robert Karol, Ph.D., LP, ABPP-RP, CBIST, President, Karol Neuropsychological Services & Consulting
    This talk will address burnout and compassion fatigue among staff working with persons following stroke. It will describe the multi-factorial nature of burnout/compassion fatigue and the top ten reasons for them. It will then review concrete steps to be taken to address these.

  4. Special Delivery: Amniotic Fluid Embolism During Labor and its Stroke-related Neurologic Complications
    Michael E. Brogan, MD, Director, Neurocritical Care, Regions Hospital; Paige J. Halvorson, MD, OB/GYN, Regions Hospital - The Birth Center; Brian S. Myer, MD, Surgeon, Trauma Services, HealthPartners Regions Specialty Clinics
    This multidisciplinary case-based discussion will include patient presentation, pathophysiology, pearls for intervention during transfusion reaction, post-arrest care, disseminated intravascular coagulation (DIC) management, neuroprotection and rehabilitation. The presenters will highlight clinical, radiologic and laboratory features of this unique case.

  5. You Never Know What Tomorrow Brings
    Celeste Ask, Stroke Survivor 6/6/11
    On June 6, 2011, Celeste Ask's healthy, busy and active lifestyle came to a complete stop when she had a massive stroke also known as a cerebral hemorrhage. At the time, she wasn't aware of what was going on and has only learned from those around her of the battle and struggle that she had learning how to live all over again. In this session, Celeste will discuss her story; the things in life that she took for granted; the support of her family and friends; the time and hard work it took to improve during the first couple years; and her new outlook on life. She hopes that by sharing her story, other people with stroke can learn that they aren't the only ones out there.

ScheduleOnline Registration
Directions and AccommodationsContinuing Education Unit InformationCancellation Policy